44.77
price down icon1.96%   -0.9846
 
loading

Livanova Plc Borsa (LIVN) Ultime notizie

pulisher
Jun 16, 2025

Global Neurostimulation Devices Market to grow at a CAGR - openPR.com

Jun 16, 2025
pulisher
Jun 15, 2025

(LIVN) Investment Report - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 14, 2025

LivaNova’s SWOT analysis: medical device firm’s stock faces growth hurdles By Investing.com - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

Wearable Cardioverter Defibrillators (WCD) Market Growth | - openPR.com

Jun 13, 2025
pulisher
Jun 11, 2025

LivaNova Shareholders Approve New Incentive Plans - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

LivaNova Shareholders Approve New Incentive Plans By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

LivaNova Shareholders Approve Key Incentive Plans at AGM - TipRanks

Jun 11, 2025
pulisher
Jun 10, 2025

Livanova petitions CMS to drop CED mandate for VNS for depression - BioWorld MedTech

Jun 10, 2025
pulisher
Jun 06, 2025

LivaNova completes epilepsy treatment study of VNS Therapy - Medical Device Network

Jun 06, 2025
pulisher
Jun 05, 2025

LivaNova reports positive VNS Therapy study results for epilepsy By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

VNS therapy shows sustained seizure reduction in study By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy - BioSpace

Jun 05, 2025
pulisher
Jun 05, 2025

LivaNova at Jefferies Conference: Strategic Growth and Challenges By Investing.com - Investing.com India

Jun 05, 2025
pulisher
Jun 05, 2025

LivaNova at Jefferies Conference: Strategic Growth and Challenges - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Artificial Heart Lung Machines Market Projected to Witness - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

LIVN Reports Promising Outcomes in Drug-Resistant Epilepsy Study - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

LIVN Reports Promising Outcomes in Drug-Resistant Epilepsy Study | LIVN Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

LivaNova reports positive VNS Therapy study results for epilepsy - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy | LIVN Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Th - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy | LIVN Stock - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

LivaNova plc (LIVN) completes CORE-VNS study - StreetInsider

Jun 05, 2025
pulisher
Jun 05, 2025

VNS therapy shows sustained seizure reduction in study - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy - Business Wire

Jun 05, 2025
pulisher
Jun 05, 2025

LivaNova (LIVN) Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy - StreetInsider

Jun 05, 2025
pulisher
Jun 04, 2025

LivaNova seeks Medicare coverage reconsideration for VNS Therapy By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

LivaNova wants CMS to reconsider neuromod for treating depression - MassDevice

Jun 04, 2025
pulisher
Jun 04, 2025

Bioelectronic Medicine Market Research Report 2025 Featuring Key PlayersMedtronic, Abbott, Boston Scientific, Cochlear, LivaNova, Soterix Medical, Bioinduction, GiMer Medical, CEFALY, BioControl - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

LivaNova Seeks Reconsideration of National Medicare Coverage for VNS Depression Treatment - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

LivaNova Initiates Process with U.S. Centers for Medicare and Me - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

LivaNova (LIVN) Seeks Expanded Medicare Coverage for VNS Therapy - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

LivaNova seeks Medicare coverage reconsideration for VNS Therapy - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression | LIVN Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

LivaNova (LIVN) Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression - StreetInsider

Jun 04, 2025
pulisher
May 29, 2025

LivaNova Announces 12-month Data from OSPREY Study - Medical Product Outsourcing

May 29, 2025
pulisher
May 28, 2025

Vagus Nerve Stimulation (VNS) Market Poised for Breakthrough Growth: From $488.5M in 2022 to $836.1M by 2032 - openPR.com

May 28, 2025
pulisher
May 27, 2025

LivaNova PLC (NASDAQ:LIVN) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 27, 2025
pulisher
May 26, 2025

Electroceuticals Market Generated Opportunities, Future - openPR.com

May 26, 2025
pulisher
May 26, 2025

LivaNova’s SWOT analysis: medical device firm’s stock faces growth hurdles - Investing.com Australia

May 26, 2025
pulisher
May 25, 2025

LivaNova's SWOT analysis: medical device firm's stock faces growth hurdles - Investing.com

May 25, 2025
pulisher
May 23, 2025

(LIVN) Technical Data - news.stocktradersdaily.com

May 23, 2025
pulisher
May 23, 2025

LivaNova PLC (NASDAQ:LIVN) Shares Acquired by Deutsche Bank AG - Defense World

May 23, 2025
pulisher
May 22, 2025

LivaNova faces $360M liability after court ruling By Investing.com - Investing.com South Africa

May 22, 2025
pulisher
May 22, 2025

LivaNova (NASDAQ:LIVN) Raised to Outperform at Wolfe Research - Defense World

May 22, 2025
pulisher
May 21, 2025

LivaNova faces $360M liability after court ruling - Investing.com Australia

May 21, 2025
$314.02
price up icon 0.34%
medical_devices PHG
$23.91
price down icon 1.06%
medical_devices STE
$238.54
price down icon 0.13%
$86.49
price up icon 0.23%
$74.26
price down icon 0.17%
medical_devices EW
$77.98
price down icon 0.29%
Capitalizzazione:     |  Volume (24 ore):